Retina-Vitreous Associates Medical Group

What Retina-Vitreous Associates Medical Group does

Retina-Vitreous Associates Medical Group (DBA: LA Retina) is a private, physician-partnership specialty practice founded in 1976 in Los Angeles, California, focused exclusively on the medical and surgical treatment of diseases of the retina, vitreous, and macula. The group employs 11 board-certified ophthalmologists with sub-specialty vitreoretinal training recruited from leading U.S. institutions, and operates 11 office locations across Southern California spanning Los Angeles, Beverly Hills, Encino, Torrance, North Hollywood, Pasadena, Glendale, La Mirada, Upland, Hesperia, and Colton. All physicians hold academic appointments at the Keck School of Medicine at the University of Southern California, and the group partners with the USC Roski Eye Institute to operate one of the top Vitreo-Retinal Fellowship training programs in the country.

The practice's clinical service line covers macular degeneration, diabetic retinopathy, retinal detachment, macular holes, uveitis, ocular tumors, retinal vein occlusions, and pediatric retinal disease, supported by an in-house Visual Function Laboratory offering full-service electrophysiology (ffERG, mf-ERG, EOG, VEP, Humphrey and Goldmann visual field, color vision) and advanced imaging (OCT, fluorescein angiography, ICG, fundus photography). The group has participated in multicenter clinical trials for novel retinal therapies for over 15 years, with senior partners serving as investigators in 100+ trials, providing both research revenue and early patient access to new treatments.

Revenue is generated principally through fee-for-service patient care reimbursed by Medicare, Medi-Cal, and most major commercial insurance plans, supplemented by clinical trial research contracts. Patient acquisition is referral-led from general ophthalmologists, augmented by a direct website (laretina.com), an annual patient newsletter (Retina Update), and a Facebook presence. The group also operates a commercial partnership with Focus Vitamins to offer AREDS2-based supplement formulations at a discount to its patients, creating a small ancillary revenue channel tied to the patient base. No private equity, venture capital, or parent-company ownership is indicated in available source material; ownership is a partnership of the 11 physicians.

Name

Retina-Vitreous Associates Medical Group

Legal name

Retina-Vitreous Associates Medical Group

Website

https://laretina.com

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

101–250 employees

Short description

Retina-Vitreous Associates Medical Group is a private Los Angeles ophthalmology partnership of 11 board-certified sub-specialists providing medical and surgical treatment of retinal, vitreous, and macular diseases across 11 Southern California locations.

Ownership category

akta.pro rank

Product category

Retina/Vitreous Ophthalmology Specialty Care

NAICS

Offices of Physicians (6211), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro industry

PRIMARYHLAKAKAE

Retina & Vitreous Specialists

Healthcare & Life Sciences/Specialist Medical Practice/Ophthalmology & Optometry

SECONDARYHLAKAKAC

Ophthalmology Clinics (Medical & Surgical Eye Care)

Healthcare & Life Sciences/Specialist Medical Practice/Ophthalmology & Optometry

SECONDARYHLAFAKAI

Vision & Ophthalmic Diagnostic Centers (Optometry/OCT/Retinal Imaging)

Healthcare & Life Sciences/Healthcare Providers & Systems/Diagnostic & Imaging Centers

Keywords

• Retinal disease treatment
• Vitreoretinal surgery
• Ophthalmic medical services
• Macular degeneration care
• Ophthalmic clinical trials

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices11 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Medical and surgical treatment services for retinal, vitreous, and macular diseases billed through insurance including Medicare, Medi-Cal, and private health insurance plans.
2. Clinical Trial Participation: Participation in multicenter clinical trials for new therapies, generating revenue through research contracts and grants while providing patients access to novel treatments.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Retina-Vitreous Associates Medical Group (LA Retina) provides medical and surgical treatment for diseases affecting the retina, vitreous, and macula, including macular degeneration, diabetic retinopathy, retinal detachment, uveitis, ocular tumors, and pediatric retinal diseases. The practice operates 11 locations across Southern California staffed by 11 board-certified ophthalmologists and is supported by an in-house Visual Function Laboratory offering electrophysiology and visual field testing. The group also actively participates in multicenter clinical trials assessing new therapies.

Product overview

Retina-Vitreous Associates Medical Group (LA Retina) operates as a specialized medical practice offering diagnostic and treatment services for retinal, vitreous, and macular diseases. The practice provides core medical and surgical treatment services complemented by an in-house Visual Function Laboratory for advanced electrophysiology and visual field testing. Additionally, the practice offers a line of vitamin supplements under the Focus Vitamins brand, including Focus Select AREDS2-based formulas in various formulations (chewable, soy-free, zinc-free), Focus PI post-injection eye drops, and Focus Relief Plus, which are available at a 10% discount for LA Retina patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Retina-Vitreous Associates Medical Group Core Services Medical and surgical diagnosis, treatment, and management of diseases affecting the retina, vitreous, and macula, including macular degeneration, diabetic retinopathy, retinal detachment, uveitis, ocular tumors, and pediatric retinal diseases; serves patients referred by general ophthalmologists and direct patient contacts.
• Visual Function Laboratory State-of-the-art diagnostic testing facility offering full-service electrophysiology including Full Field Electroretinogram (ffERG), Multifocal ERG, Visual Evoked Potential (VEP/VER), Humphrey Visual Field, Goldmann Visual Field, Octopus Static Visual Field, Farnsworth-Munsell D-15, and Farnsworth-Munsell 100 Hue color vision tests; staffed by certified technicians and photographers and serving patients requiring advanced retinal functional testing.
• Clinical Trials Program Active participation in multicenter clinical trials assessing new therapies for retinal, vitreous, and macular diseases (notably macular degeneration and diabetic retinopathy), providing patients access to investigational treatments not yet commercially available; the practice has participated in clinical research for over 15 years.
• Macular Degeneration Treatment Medical and surgical treatment of macular degeneration using advanced imaging technologies such as Optical Coherence Tomography (OCT), Fluorescein angiography, and Indocyanine Green Angiography (ICG) to image the macula and guide treatment.
• Diabetic Retinopathy Treatment Diagnosis and medical/surgical management of diabetic retinopathy, including access to clinical trials investigating new therapies for the condition.
• Retinal Detachment Surgery Surgical repair of retinal detachments performed by board-certified vitreoretinal surgeons at the practice's 11 Southern California locations.
• Uveitis Treatment Medical management of uveitis and ocular inflammatory diseases, including diagnosis and treatment by physicians with subspecialty uveitis training such as Dr. Pouya N. Dayani and Dr. Firas Rahhal.
• Ocular Tumor Treatment Diagnosis and management of ocular tumors affecting the retina and vitreous, provided by board-certified vitreoretinal specialists.

Quantifiable outcome

• Patients who have exhausted standard treatment options may find relief by participation in clinical trials
• +1 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core and minor.

• USC Roski Eye InstitutecoreStrategic or Co-development PartnerPartnership with USC Roski Eye Institute to form one of the top Vitreo-Retinal Fellowship training programs in the country. All doctors hold academic appointments at Keck School of Medicine at University of Southern California. The group actively participates in medical education, teaching, and training of the next generation of vitreoretinal surgeons.
• Focus VitaminsminorGTM or Marketing PartnerFocus Vitamins is a physician-founded and led supplement company that provides various formulations to improve macular health. As a trusted partner of LA Retina, Focus Vitamins offers AREDS2 based formulas with a 10% discount for LA Retina patients.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Retina Consultants of America: A national network of retinal specialty practices consolidated under private equity ownership. Operates as a multi-state platform of similar vitreoretinal specialists, directly comparable in service mix but with materially greater geographic reach and scale.
• Jules Stein Eye Institute (UCLA): Academic ophthalmology department at UCLA with retina faculty who are direct competitors for referrals in the LA market. Several RVA physicians hold prior or current academic ties to UCLA — comparable retinal expertise and trial access but embedded in a broader academic medical center.
• Doheny Eye Institute (USC): USC-affiliated ophthalmology research and clinical institute with retina faculty. Direct competitor for retinal referrals in the LA market and partner in the broader USC ophthalmology ecosystem alongside RVA's Roski Eye Institute relationship.
• EyeCare Partners: PE-backed national ophthalmology and optometry platform. Competes with RVA for both patients and physician talent in the LA market through its consolidated specialty groups, representing the larger strategic threat to independent retina practices.

Direct peers

• Associated Retina Consultants: Multi-physician vitreoretinal specialty practice with multiple clinical trial programs. Similar physician-partnership model, retina-only focus, and active participation in national clinical trials for AMD and diabetic retinopathy.
• California Retina Consultants: Multi-location California-based retina specialty practice with strong clinical trial infrastructure. Directly comparable in service mix, geographic base, and trial participation model.
• Mid Atlantic Retina: Multi-physician vitreoretinal specialty practice with academic affiliations and significant clinical trial activity. Comparable specialist-only practice model with regional multi-site footprint.
• Texas Retina Associates: Large physician-partner vitreoretinal specialty practice with numerous locations across Texas. Similar in scale (~15+ physicians), specialization model, and active clinical trial participation.
• Retina Group of Washington: Multi-physician retina specialty practice with academic affiliations (Georgetown/Washington Hospital Center). Comparable in physician partnership structure, retina-only focus, and clinical trial activity.

Regional players

• Retina-Vitreous Associates of New York: Independent vitreoretinal specialty practice serving the New York metro area. Comparable in physician partnership model and clinical trial participation, but operates in a different geographic market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Retina-Vitreous-Associates-Medical-Group-143262122414280

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retina-Vitreous Associates Medical Group